Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell, Marginal Zone

Explore clinical trials studying Lymphoma, B-Cell, Marginal Zone. Study availability and eligibility vary by location and protocol.

647 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell, Marginal Zone trial results

Enrolling by invitation

Watch and Wait or Worry and Wait in Indolent Lymphoma

NCT07173790

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
Locations
  • Samsung Medical Center Seoul, Gangnam-gu, South Korea
  • Korea UniversityKorea University Guro Hospital Seoul, Guro-gu, South Korea
  • Seoul National University Hospital Seoul, Jongno-gu, South Korea
  • The Catholic University of Korea Seoul, Seocho-gu, South Korea
View Trial Details
Active, not recruiting

Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma

NCT05783596

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Irving Medical Center New York, United States
  • Mount Sinai Medical Center New York, United States
View Trial Details
Active, not recruiting

A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

NCT05100862

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • Ucsf Fresno University of California San Francisco Fresno Fresno, California, United States
  • Kaiser Permanente Southern California Irvine, California, United States
  • Cancer and Blood Specialty Clinic Los Alamitos, California, United States
  • Los Angeles Cancer Network Los Angeles, California, United States
View all 264 locations
View Trial Details
Active, not recruiting

Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)

NCT04542824

Conditions
Chronic Disease, Diffuse Large B Cell Lymphoma, Disease Attributes, +25 more
Locations
  • Tohoku University Hoaspital Sendai, Miyagi, Japan
  • Aichi Cancer Center Hospital Aichi, Japan
  • NHO Nagoya Medical Center Aichi, Japan
  • National Cancer Center Hospital East Chiba, Japan
View all 15 locations
View Trial Details
Active, not recruiting

First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma

NCT03625037

Conditions
Aggressive B-cell Non-Hodgkin Lymphoma (aNHL), Chronic Disease, DLBCL, +26 more
Locations
  • Arizona Mayo Clinic Phoenix, Arizona, United States
  • University of California at San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 85 locations
View Trial Details

Related conditions